FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

14 letters match. Newest first.

  1. Vacation Inc.

    FDA warned Vacation Inc. that its whipped-cream-style sunscreen mousses are unapproved drugs and that their food-like cans are misleading.

    High risk
  2. Kalani AB dba Kalani Sunwear

    FDA warns Kalani AB that its Sun Mousse SPF 50 sunscreen is an unapproved, misbranded drug for US sale.

    High risk
  3. K & Care Organics

    FDA warns K & Care Organics over unapproved over-the-counter (OTC) foam sunscreen drugs sold in the U.S. without required authorization.

    High risk
  4. Fallien Cosmeceuticals Ltd. dba Fallene Ltd.

    FDA warns Fallien over unapproved OTC sunscreen foam TiZO SHEERFOAM SPF 30 sold without required authorization.

    Medium
  5. Supergoop!

    FDA warned Supergoop! that its over-the-counter sunscreen body mousse is illegally labeled because foam dosage forms are not allowed under the sunscreen monograph.

    Medium
  6. Shenzhen Hengkaifeng Commerce and Trade Co., Ltd

    Shenzhen Hengkaifeng's Sensitivity Toothpastes listing was inaccurate, making the drug misbranded, FDA says.

    Low
  7. Kabana Skin Care

    FDA warned Kabana Skin Care that its "Kabana Body Wash +UV" is an unapproved, misbranded sunscreen drug sold without required FDA clearance.

    Medium
  8. Waxhead Sun Defense Company

    FDA warned Waxhead Sun Defense Company that its zinc body wash/shampoo is an unapproved, misbranded OTC sunscreen drug.

    Medium
  9. CoLabs Intl. Corp

    CoLabs Intl. Corp marketed KLĒNSKIN WASH ON SUNSCREEN, an OTC sunscreen wash, without an FDA-approved application or authorized dosage form.

    Medium
  10. Dr Sankunni’s Ayurvedic Research Foundation Private Ltd.

    Dr Sankunni's Ayurvedic Research Foundation failed to correct drug listing and registration errors for its balms and hand sanitizer.

    Low
  11. US Specialty Formulations, LLC

    US Specialty Formulations, a drug compounder registered as an outsourcing facility, made sterile compounded drugs under insanitary conditions.

    High risk
  12. Lydia Co. Ltd.

    Lydia Co. Ltd. submitted mismatched drug listing data for eight products, leading FDA to remove them from its NDC Directory.

    Low
  13. New England Life Care, Inc. dba Advanced Compounding Solutions

    FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.

    High risk
  14. Maitland Labs of Central Florida

    FDA warns Maitland Labs of Central Florida over sterile compounded drugs with manufacturing quality failures, mislabeling, and unapproved new drug violations.

    High risk